The Effect of Hormonal Contraceptives on Breast-milk Production & Infant

Status Completed

Clinical Trial Summary

The investigators propose a randomized clinical trial comparing the effect of 30 mcg ethinyl estradiol and LNG 150 combination oral contraceptive pills versus placebo, or LNG-IUS or Etonogestrel-releasing contraceptive implant (Implanon)on breast-milk intake and infant growth in exclusively breastfeeding mother-infant pairs. Mother-infant pairs will be randomly assigned either 30 microgram ethinyl estradiol combination oral contraceptive pills or identical placebo to start on post-partum day number 42 or Implanon implants or a LNG-IUS. All women will be offered nonhormonal contraceptives prior to randomization. The pairs will then be followed for four weeks. During this follow-up period, breast-milk intake will be quantified by administering deuterium oxide to exclusively breast-feeding mothers and measuring the enrichment of deuterium oxide in the saliva of their infants, otherwise known as the dose-to-mother method of Coward.17 Additionally, maternal and infant anthropometric measurements will be collected -- both as a value necessary to implement the breast-milk quantification method, as well as an outcome for analysis, and a daily diary will be kept by the women participating in the study that records infant feeds and diaper changes.

Clinical Trial Description

Women where allocated to an oral combined contraceptive pill, or placebo or a LNG-IUS or a etonogestrel-releasing subdermal contraceptive implant at day 42 after delivery. After the provision of the contraceptive method a 0.5 mg/kg of deuterium 99.99% according to the weight of the mother will be administer to all women. One sample of saliva from the mother and the child will be collected every day until 21 days after enrollment. Additionally, weight, height and size of the leg of each child will be measured at baseline, at the day 11 and at the day 21 after enrollment. Also, a diary with information of change of diapers and number of breastfeeding will be kept by each mother. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Underweight

Clinical Trial Details

NCT number	NCT01388582
Study type	Interventional
Source	University of Campinas, Brazil
Contact
Status	Completed
Phase	Phase 4
Start date	April 2011
Completion date	August 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02451410` - An Intervention to Improve Nutrition and Physical Activity in Preschoolers in Cuenca, Ecuador	N/A
Not yet recruiting	`NCT05517395` - The Effectiveness of HBM-based Education Program on Improve Knowledge and Behaviors	N/A
Active, not recruiting	`NCT05248516` - ComPAS Low-WAZ RCT Mali	Phase 2/Phase 3
Completed	`NCT04561635` - Effects of Multiple-micronutrients Supplementation on Growth and Iron Status of Indigenous Children in Malaysia	N/A
Recruiting	`NCT03398343` - Nutritional Therapy on Underweight Critically Ill Patients: an Observational Study	N/A
Completed	`NCT01553552` - Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal	N/A
Completed	`NCT05574842` - The Effect of Double Duty Interventions on Double Burden of Malnutrition Among School Adolescents in Ethiopia	N/A
Completed	`NCT05077059` - Prevalence of Obesity and Overweight in Primary School Children in the Rhein-Neckar Region in Germany
Completed	`NCT03847662` - Scaling up Small-Scale Food Processing to Promote Food Security Among Women Farmers in Rural Vietnam
Completed	`NCT03378141` - Maternal Nutrition Interventions in Uttar Pradesh, India	N/A
Completed	`NCT05346549` - Energy Regulation and Nutritional Status of Children: A Satiation Study	N/A
Completed	`NCT04851327` - Satiation Study With Children Attending a Tertiary Feeding Clinic	N/A
Completed	`NCT04848129` - Genetic Correlates of Wasting: a Pilot Study With Children Attending a Tertiary Feeding Clinic
Completed	`NCT03523182` - Spirulina Supplementation and Infant Growth, Morbidity and Motor Development	N/A
Recruiting	`NCT05881447` - Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Completed	`NCT04631978` - Analysis of Retinochoroidal Vasculature in Underweight Women Using Optical Coherence Tomography Angiography
Active, not recruiting	`NCT05952076` - Impact of Bi-26 Supplementation on Weight Gain in Underweight Infants	Phase 3
Not yet recruiting	`NCT06309576` - Experimental Approach to Test Predictions of Body Weight Regulation Models	N/A
Not yet recruiting	`NCT05457712` - Nutrition In Preoperative Pediatric Congenital Heart Disease	N/A
Active, not recruiting	`NCT03638557` - School Lunch Program (SLP) Towards Nutrition Knowledge, Attitude, Practices and Nutrition Status of Adolescents	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Effect of Hormonal Contraceptives on Breast-milk Production and Infant Growth

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms